A Phase 1 Study of CCI-779 [temsirolimus] in Combination With Dexamethasone in Multiple Myeloma.
Phase of Trial: Phase I
Latest Information Update: 03 Jun 2013
At a glance
- Drugs Dexamethasone (Primary) ; Temsirolimus (Primary)
- Indications Multiple myeloma
- Focus Adverse reactions
- 10 Jun 2017 Biomarkers information updated
- 14 Feb 2011 Actual end date (Aug 2010) added as reported by ClinicalTrials.gov.
- 14 Feb 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.